Research Topics
Genomes and GenesSpecies | L N YathamSummaryAffiliation: University of British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Oxcarbazepine add-on in the treatment of refractory bipolar disorderWetid Pratoomsri
Mood Disorders Clinical Research Unit, The University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:37-42. 2005..CONCLUSION: OXC was effective and well-tolerated in refractory BD and schizoaffective disorder. These preliminary data are promising but controlled studies are needed to confirm its efficacy in refractory BD...
Oxcarbazepine in the treatment of bipolar disorder: a reviewWetid Pratoomsri
Mood Disorders Centre of Excellence, University of British Columbia, Vancouver
Can J Psychiatry 51:540-5. 2006....
Assessment of noradrenergic functioning in patients with non-combat-related posttraumatic stress disorder: a study with desmethylimipramine and orthostatic challengesL N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Psychiatry Res 63:1-6. 1996..Overall, these findings suggest that non-combat-related PTSD patients have peripheral noradrenergic dysregulation, but central postsynaptic alpha 2-adrenergic receptor sensitivity is not altered in this patient population...
PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodiumLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Am J Psychiatry 159:768-74. 2002....
A PET study of brain 5-HT2 receptors and their correlation with platelet 5-HT2 receptors in healthy humansL N Yatham
Division of Mood Disorders Clinical Research Unit, The University of British Columbia, Vancouver, Canada
Psychopharmacology (Berl) 151:424-7. 2000..Platelets share many properties with brain serotonergic neurons such as active 5-hydroxytryptamine (5-HT) transport, 5-HT2 receptors, and mitochondrial monoamine oxidase...
Brain serotonin2 receptors in major depression: a positron emission tomography studyL N Yatham
Mood Disorders Clinical Research Unit, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, British Columbia, Canada V6T 2A1
Arch Gen Psychiatry 57:850-8. 2000..1 +/- 9.5 years; range, 22-60 years) and 20 healthy controls similar in age (37.2 +/- 12.6 years; range, 19-59 years) using positron emission tomography and setoperone labeled with fluorine 18 ([(18)F]setoperone)...
Effects of rapid tryptophan depletion on brain 5-HT(2) receptors: a PET studyL N Yatham
Division of Mood Disorders, The University of British Columbia, Canada
Br J Psychiatry 178:448-53. 2001..The mechanism by which rapid tryptophan depletion (RTD) paradigm induces depressive relapse in recently remitted patients with depression is unknown...
Hypothermic, ACTH, and cortisol responses to ipsapirone in patients with mania and healthy controlsL N Yatham
Department of Psychiatry, The University of British Columbia, Vancouver, Canada
J Affect Disord 54:295-301. 1999....
Decrease in brain serotonin 2 receptor binding in patients with major depression following desipramine treatment: a positron emission tomography study with fluorine-18-labeled setoperoneL N Yatham
Division of Mood Disorders, The University of British Columbia, Vancouver, Canada
Arch Gen Psychiatry 56:705-11. 1999..Our purpose, therefore, was to assess the effects of treatment with desipramine hydrochloride on brain 5-HT2 receptors in depressed patients using positron emission tomography (PET) and fluorine-18 (18F)-labeled setoperone...
PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic maniaLakshmi N Yatham
Mood Disorders Clinical Research Unit, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada V6T 2A1
Am J Psychiatry 159:1718-23. 2002..The purpose of this study was to further examine D(2) receptor density in a larger sample of nonpsychotic manic patients by using positron emission tomography (PET) and [(11)C]raclopride...
Bipolar depression: treatment optionsL N Yatham
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 42:87S-91S. 1997..To review studies on treatments for bipolar depression and make recommendations for practising clinicians treating patients with bipolar depression...
L-tryptophan augmentation of light therapy in patients with seasonal affective disorderR W Lam
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 42:303-6. 1997..Given the evidence for serotonergic dysregulation in SAD, we examined the possible role of l-tryptophan as an augmentation strategy for nonresponders and partial responders to light therapy...
Effects of light therapy on suicidal ideation in patients with winter depressionR W Lam
Department of Psychiatry, University of British Columbia, and the University of British Columbia Hospital, Vancouver, Canada
J Clin Psychiatry 61:30-2. 2000..This retrospective study sought to determine the effects of light therapy on suicidal ideation in patients with SAD...
Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperoneE T Ngan
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
Am J Psychiatry 157:1016-8. 2000..The authors compared serotonin receptor binding in patients with schizophrenia and healthy comparison subjects...
Seasonal depression: the dual vulnerability hypothesis revisitedR W Lam
Division of Mood Disorders, Department of Psychiatry, University of British Columbia Hospital, Vancouver Hospital and Health Sciences Centre, 2255 Wesbrook Mall, BC, Canada V6T 2A1
J Affect Disord 63:123-32. 2001..In this study, we compare the clinical characteristics of these three seasonal groups and their response to light therapy...
A controlled study of light therapy in women with late luteal phase dysphoric disorderR W Lam
Department of Psychiatry, University of British Columbia, Vancouver Hospital and Health Sciences Centre, Canada
Psychiatry Res 86:185-92. 1999..These results suggest that bright light therapy is an effective treatment for LLPDD...
Effects of alpha-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remissionR W Lam
Division of Mood Disorders, Department of Psychiatry, University of British Columbia, and UBC Hospital, Vancouver Hospital and Health Sciences Centre, Vancouver, B C, Canada
Neuropsychopharmacology 25:S97-101. 2001..AMPT-induced depressive relapse may be a trait marker for SAD, and/or brain catecholamines may play a direct role in the pathogenesis of SAD...
An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosaR W Lam
Department of Psychiatry, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 62:164-8. 2001..Controlled studies of light therapy in SAD and in bulimia nervosa have shown beneficial effects on mood and binge/purge symptoms. We explored the clinical use of light therapy in women with SAD who also had comorbid bulimia nervosa...
Clinical predictors of short-term outcome in electroconvulsive therapyR W Lam
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 44:158-63. 1999..This study examined ECT use in a university teaching hospital to determine predictors of short-term ECT outcome...
Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute maniaD S Miller
Department of Psychiatry, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 62:975-80. 2001..atypical antipsychotics are an excellent choice as add-on therapy to mood stabilizers for the treatment of patients with mania...
Decreased mRNA expression of uncoupling protein 2, a mitochondrial proton transporter, in post-mortem prefrontal cortex from patients with bipolar disorder and schizophreniaA D Gigante
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Neurosci Lett 505:47-51. 2011..Although more studies are necessary, our results suggest that UCP2 is not been used as a compensatory mechanism to oppose the higher levels of oxidative stress found in BD and SCZ...
Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorderI J Torres
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
Psychol Med 41:971-82. 2011..The purpose of this study was to evaluate the impact of cognitive functioning on longitudinal 6-month functional and clinical outcome in recently diagnosed clinically stable patients with bipolar disorder...
Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of maniaLakshmi N Yatham
University of British Columbia, Vancouver, British Columbia Janssen Ortho Inc, Toronto, Canada
Int Clin Psychopharmacol 19:103-9. 2004..These data suggest that risperidone can be safely combined with either lithium or valproate, and that the efficacy is similar regardless of the mood stabilizer used...
A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar maniaLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, UBC Hospital, Vancouver, British Columbia, Canada
Int Clin Psychopharmacol 22:212-20. 2007..Overall, the combination of quetiapine with lithium or divalproex was well tolerated...
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversiesLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:5-69. 2005..These guidelines also discuss issues related to bipolar disorder in women and those with comorbidity and include a section on safety and monitoring...
Atypical antipsychotics in bipolar depression: potential mechanisms of actionLakshmi N Yatham
Department of Psychiatry, The University of British Columbia, UBC Hospital, Vancouver, Canada
J Clin Psychiatry 66:40-8. 2005..Further studies should be conducted to examine these hypotheses...
Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studiesKaveh M Koochesfahani
Pacific Parkinson s Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
Mov Disord 21:970-5. 2006..Our data provide in vivo neurochemical support for the lack of clinical efficacy following MP in PD patients and are also in keeping with reduced DA release following amphetamine in PD subjects...
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007Lakshmi N Yatham
Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, Canada
Bipolar Disord 8:721-39. 2006..The importance of comorbid psychiatric and medical conditions cannot be understated, and this update provides an expanded look at the prevalence, impact and management of comorbid conditions in patients with bipolar disorder...
A magnetic resonance imaging study of mood stabilizer- and neuroleptic-naïve first-episode maniaLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 9:693-7. 2007..Studies in first-episode (FE) manic patients have the potential to provide answers to these questions...
Pharmacotherapy of bipolar II disorder: a critical review of current evidenceGeorge Hadjipavlou
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Bipolar Disord 6:14-25. 2004..More quality research is needed to delineate effective treatment strategies...
Risperidone in acute and continuation treatment of maniaLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Int Clin Psychopharmacol 18:227-35. 2003..Risperidone add-on does not induce depressive symptoms and, furthermore, risperidone may have efficacy in treating comorbid depressive symptoms in bipolar patients...
Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment optionsLakshmi N Yatham
Department of Psychiatry, The University of British Columbia, Vancouver, British Columbia, Canada
Bipolar Disord 5:85-97. 2003..This paper reviews controlled studies of bipolar depression, outlines criteria for choosing treatment, defines refractoriness in bipolar depression, and provides options for treatment of refractory bipolar depression...
Quality of life in bipolar disorder: a review of the literatureErin E Michalak
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Health Qual Life Outcomes 3:72. 2005..We identified several important avenues for future research, including a need for more assessment of QoL in hypo/manic patients, more longitudinal research and the development of a disease-specific measure of QoL for patients with BD...
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trialsMark A Frye
Mood Disorders Research Program, University of California at Los Angeles, USA
J Clin Psychiatry 67:1721-8. 2006..Subsyndromal symptoms in bipolar disorder can cause significant functional impairment and are associated with relapse...
Bipolar spectrum disorders. New perspectivesAndre Piver
Nelson Mental Health Centre, Kootenay Lake Regional Hospital, Nelson, BC
Can Fam Physician 48:896-904. 2002..To review new perspectives on diagnosis, clinical features, epidemiology, and treatment of bipolar II and related disorders...
Mood stabilization and the role of antipsychoticsLakshmi N Yatham
Mood Disorders Clinical Research Unit, Department of Psychiatry, University of British Columbia, Vancouver, Canada
Int Clin Psychopharmacol 17:S21-7. 2002..This article will review the results from open and double-blind studies with quetiapine, ziprasidone, risperidone and olanzapine in the management of bipolar disorder...
Bipolar disorder and quality of life: a patient-centered perspectiveErin E Michalak
Division of Mood Disorders, Department of Psychiatry, University of British Columbia, Vancouver, BC V6T 2A1, Canada
Qual Life Res 15:25-37. 2006..We report here on a series of in-depth qualitative interviews we conducted as part of the item generation phase for a disease-specific scale to assess QoL in BD...
Polytherapy in bipolar disorderDaniel Lin
Department of Psychiatry, University of British Columbia, Vancouver, Canada
CNS Drugs 20:29-42. 2006..Similarly, the combination of lithium or valproate plus olanzapine seems to be more effective than monotherapy with a mood stabiliser in preventing manic episodes...
Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar maniaK N Roy Chengappa
Western Psychiatric Institute and Clinic, Mayview State Hospital, University of Pittsburgh Medical Center, PA 15213 2593, USA
Bipolar Disord 5:1-5. 2003....
A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute maniaLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:53-7. 2005..To examine the effects of treatment with valproate on brain 5-HT2A receptors in acute manic patients using positron emission tomography (PET) and [18F]-setoperone...
The impact of bipolar disorder upon work functioning: a qualitative analysisErin E Michalak
Division of Mood Disorders, Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada
Bipolar Disord 9:126-43. 2007..In order to further elucidate the relationship between BD and work, we report here on a series of exploratory qualitative interviews undertaken to develop a disease-specific measure of quality of life in BD...
Comment on "Antidepressant treatment-emergent switch in bipolar disorder: a prospective case-control study of outcome"Lakshmi N Yatham
Rev Bras Psiquiatr 29:86-7; author reply 87-8. 2007
The role of novel antipsychotics in bipolar disordersLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 63:10-4. 2002..Olanzapine, another novel antipsychotic, is also effective against both manic and depressive symptoms and in the maintenance treatment as indicated by an open-label study. Data on other novel agents are more limited...
Emotional memory in bipolar disorderMárcia Kauer-Sant'Anna
Mood Disorders Centre, University of British Columbia, 2C7 2255 Wesbrook Mall, Vancouver, Canada V6T 2A1
Br J Psychiatry 192:458-63. 2008..Cognitive impairment has been well documented in bipolar disorder. However, specific aspects of cognition such as emotional memory have not been examined...
Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patientsRao N Malempati
Mood and Anxiety Disorders Program, Hotel Dieu Grace Hospital, Windsor, Ontario, Canada
Int Clin Psychopharmacol 23:88-94. 2008..Clinicians may consider risperidone Consta as an option in patients with refractory bipolar illness, including those with a predominantly depressive course, and particularly in patients' nonadherence with prescribed medications...
Pure and mixed manic subtypes: a review of diagnostic classification and validationFrederick Cassidy
Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
Bipolar Disord 10:131-43. 2008..To review issues surrounding the diagnosis and validity of bipolar manic states...
Diagnostic guidelines for bipolar disorder: a summary of the International Society for Bipolar Disorders Diagnostic Guidelines Task Force ReportS Nassir Ghaemi
Bipolar Disorder Research Program, Department of Psychiatry, Emory University, Atlanta, GA 30322, USA
Bipolar Disord 10:117-28. 2008....
Third generation anticonvulsants in bipolar disorder: a review of efficacy and summary of clinical recommendationsLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 63:275-83. 2002..To review the literature on efficacy of third generation anticonvulsants for treatment of bipolar disorder and provide clinical recommendations...
Setting the stage: from prodrome to treatment resistance in bipolar disorderMichael Berk
Barwon Health and The Geelong Clinic, Geelong, Victoria, Australia
Bipolar Disord 9:671-8. 2007..At the other end of the spectrum, the model attempts to operationalize treatment resistance. The utility of the model will need to be validated by empirical research...
Traumatic life events in bipolar disorder: impact on BDNF levels and psychopathologyJuliana Tramontina
Post Graduate Biochemistry Program, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil
Bipolar Disord 9:128-35. 2007....
Electroretinography in patients with winter seasonal affective disorderMarc Hebert
Department of Ophthalmology, Laval University Medical Research Center CHUQ, Faculty of Medicine, Laval University, Sainte Foy, Quebec, Canada
Psychiatry Res 127:27-34. 2004..We hypothesize that brain neurotransmitter dysregulation may be at the origin of both the mood disorder and retinal sensitivity change...
Effect of valproate on plasma levels of interleukin-6 in healthy male humansI Shin Shiah
Department of Psychiatry, Tri Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Int Clin Psychopharmacol 20:295-8. 2005....
Atypical antipsychotics for bipolar disorderLakshmi N Yatham
Mood Disorders Clinical Research Unit, University of British Columbia, Room 2C7 2255 Wesbrook Mall, Vancouver, BC V6T 2A1, Canada
Psychiatr Clin North Am 28:325-47. 2005..Overall, the atypical antipsychotic agents as a group represent an effective and relatively safe addition to the armamentarium for the treatment of bipolar disorder...
Comorbidity in bipolar disorder: a framework for rational treatment selectionRoger S McIntyre
Mood Disorder Psychopharmacology Unit, University of Toronto, University Health Network Toronto Western Hospital, 399 Bathurst Street, Toronto, Ontario M5T 2S9, Canada
Hum Psychopharmacol 19:369-86. 2004..This schema should be further informed by the treatment data for comorbid and accessory conditions. The authors propose a schema to provide the impetus for further work in the area...
Newer anticonvulsants in the treatment of bipolar disorderLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, British Columbia, Canada
J Clin Psychiatry 65:28-35. 2004..This article summarizes current evidence from trials of anticonvulsants in bipolar disorder and makes recommendations for their clinical use...
International Consensus Group on Bipolar I Depression Treatment GuidelinesJoseph R Calabrese
Department of Psychiatry, Case Western Reserve University, Cleveland, OH, USA
J Clin Psychiatry 65:571-9. 2004
Efficacy of atypical antipsychotics in mood disordersLakshmi N Yatham
University of British Columbia, Vancouver, Canada
J Clin Psychopharmacol 23:S9-14. 2003....
Olanzapine versus placebo in acute mania: treatment responses in subgroupsRoss J Baldessarini
International Consortium for Bipolar Disorder Research, Department of Psychiatry and Neuroscience Program, Harvard Medical School, Boston, MA, USA
J Clin Psychopharmacol 23:370-6. 2003..5-1.7, all P < 0.01). These well-powered comparisons of subgroups of interest indicate broad efficacy of olanzapine in the treatment of acute mania...
Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophreniaCarol J Lane
Department of Psychiatry, University of British Columbia, Vancouver, BC
J Psychiatry Neurosci 29:30-7. 2004....
Acute and maintenance treatment of bipolar mania: the role of atypical antipsychoticsLakshmi N Yatham
Mood Disorders Clinical Research Unit, The University of British Columbia, Vancouver, BC, V6T 2A1, Canada
Bipolar Disord 5:7-19. 2003..The atypical antipsychotics represent an effective and relatively safe addition to our armamentarium for the treatment of bipolar disorder...
Advances in treatment of mood and anxiety disorders: focus on atypical antipsychoticsLakshmi N Yatham
University of British Columbia, Vancouver, BC
Bipolar Disord 5:5-6. 2003
Quality of life in patients with bipolar I depression: data from 920 patientsLakshmi N Yatham
The University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 6:379-85. 2004..To determine the impact of acute depression on quality of life (QOL) in patients with bipolar I disorder and to compare these results with published data on QOL in patients with unipolar depression...
Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled dataEduard Vieta
Bipolar Disorders Program, Department of Psychiatry, Hospital Clinic, University of Barcelona, IDIBAPS, Barcelona, Spain
J Clin Psychiatry 65:1420-8. 2004..We report on the first controlled study comparing acute and continuous clinical outcomes in RC and non-RC manic patients treated with olanzapine...
Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar maniaLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
J Clin Psychopharmacol 24:599-606. 2004..Quetiapine, in combination with lithium or divalproex, is well tolerated and has superior efficacy to lithium or divalproex alone in the treatment of bipolar mania...
Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trialMauricio Tohen
Lilly Research Laboratories, Indianapolis, IN 46285, USA
Am J Psychiatry 162:1281-90. 2005..The authors compared the efficacy of olanzapine and lithium in the prevention of mood episode relapse/recurrence...
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorderCharles L Bowden
Department of Psychiatry, University of Texas Health Science Center at San Antonio, 78229, USA
Arch Gen Psychiatry 60:392-400. 2003....
Translating knowledge of genetics and pharmacology into improving everyday practiceLakshmi N Yatham
Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
Bipolar Disord 7:13-20. 2005....
Lamotrigine for bipolar disorder: translating research into clinical practiceJonathan Fung
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Expert Rev Neurother 4:363-70. 2004..Practical recommendations regarding titration and the management of rash are offered...
Perceived quality of life in patients with bipolar disorder. Does group psychoeducation have an impact?Erin E Michalak
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 50:95-100. 2005..We aimed to assess the impact of a time-limited psychoeducation (PE) group therapy upon perceived QoL among patients with BD...
Diagnosis and management of patients with bipolar II disorderLakshmi N Yatham
Division of Mood Disorders, University of British Columbia, Vancouver, Canada
J Clin Psychiatry 66:13-7. 2005..Hypomania will likely respond to monotherapy with antimanic agents. Adjunctive psychosocial treatments may provide additional benefit in patients with bipolar II disorder...
Bipolar II disorder: an overview of recent developmentsGeorge Hadjipavlou
Department of Psychiatry, University of British Columbia, Vancouver
Can J Psychiatry 49:802-12. 2004..More well-designed studies with larger samples are needed to improve the evidence base for managing this disorder...
Recovery and functional outcomes following olanzapine treatment for bipolar I maniaK N Roy Chengappa
Western Psychiatric Institute and Clinic, University of Pittsburgh, School of Medicine, Pittsburgh, PA 15213 2593, USA
Bipolar Disord 7:68-76. 2005..Typical experimental categorizations of treatment responses in bipolar disorder (BPD) patients may have limited relationship to clinical recovery or functional status, and there is inadequate research on such clinically important outcomes...
A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorderJoseph R Calabrese
University Hospitals of Cleveland Case Western Reserve School of Medicine, Department of Psychiatry, 11400 Euclid Ave, Ste 200, Cleveland, OH 44106, USA
J Clin Psychiatry 64:1013-24. 2003..This study assessed the efficacy and tolerability of lamotrigine and lithium compared with placebo for the prevention of mood episodes in bipolar disorder...
